Responsible investors have tabled shareholder resolutions calling on US pharmaceutical companies to offer Covid vaccines at affordable prices - especially when they have been developed using substantial levels of public funding.
Members of the Interfaith Center on Corporate Responsibility (IICR) in the US have filed proposals at Eli Lilly, J&J, Merck, Pfizer, Gilead and Regeneron ahead of their 2021 AGMs.
The lead filers at the firms, in order, are: Mercy Investment Services, Oxfam America, Seventh Generation Interfaith Coalition for Responsible Investment, Trinity Heath and Boston Common Asset Management.
“Pharma companies will face significant reputational and legal risks if they are even remotely seen to be profiteering from this deadly pandemic,” said Lauren Compere of Boston Common, pointing to a recent poll showing that nine out of 10 Americans are concerned that drug companies will use the pandemic to raise prices. “Those compan…